2023-2029 Global Owren's Disorder Industry Research & Trends Analysis Report
According to Latest Research, the global market for Owren's Disorder should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Owren's Disorder market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Owren's Disorder market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Prothrombin Complex segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospitals has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Owren's Disorder include Pfizer Inc, Merck KGaA, Sanofi, Biocare Medical, LLC, Lilly, Teva Pharmaceutical Industries, Mitsubishi Chemical Group Corporation, Bristol-Myers Squibb Company and GSK plc, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Owren’s disease is also termed as Factor V or parahemophilia. It is a type of rare bleeding disorder that results in poor clotting after an injury or surgery. Factor V deficiency should not be mixed with factor V Leiden mutation, which is a much more common condition that leads to severe blood clotting.
This report aims to provide a comprehensive study of the global market for Owren's Disorder. Report Highlights:
(1) Global Owren's Disorder market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Owren's Disorder market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Owren's Disorder market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Owren's Disorder segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Owren's Disorder segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Owren's Disorder, capacity, production and trends.
(7) Owren's Disorder industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Prothrombin Complex
Desamino-D-Arginine Vasopressin
Adrenocorticotropic Hormone
Antifibrinolytics
Other
Market segment by application, can be divided into
Hospitals
Specialty Clinics
Other
Market segment by players, this report covers
Pfizer Inc
Merck KGaA
Sanofi
Biocare Medical, LLC
Lilly
Teva Pharmaceutical Industries
Mitsubishi Chemical Group Corporation
Bristol-Myers Squibb Company
GSK plc
Bayer AG
AstraZeneca
Zimmer Biomet
DAIICHI SANKYO COMPANY, LIMITED
Crystal Genomics Inc
ABIOGEN PHARMA S.p.A
1 Market Overview
1.1 Owren's Disorder Definition
1.2 Global Owren's Disorder Market Size and Forecast
1.2.1 By Revenue, Global Owren's Disorder Market Size, 2018-2029
1.2.2 By Sales Volume, Global Owren's Disorder Market Size, 2018-2029
1.2.3 Global Owren's Disorder Price Trend, 2018-2029
1.3 China Owren's Disorder Market Size and Forecast
1.3.1 By Revenue, China Owren's Disorder Market Size, 2018-2029
1.3.2 By Sales Volume, China Owren's Disorder Market Size, 2018-2029
1.3.3 China Owren's Disorder Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Owren's Disorder Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Owren's Disorder Share in Global Market, 2018-2029
1.4.3 Owren's Disorder Market Size: China VS Global, 2018-2029
1.5 Owren's Disorder Market Dynamics
1.5.1 Owren's Disorder Market Drivers
1.5.2 Owren's Disorder Market Restraints
1.5.3 Owren's Disorder Industry Trends
1.5.4 Owren's Disorder Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Owren's Disorder Revenue by Company, 2018-2023
2.2 Global Owren's Disorder Sales Volume by Company, 2018-2023
2.3 Global Owren's Disorder Price by Company, 2018-2023
2.4 Global Owren's Disorder Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Owren's Disorder Concentration Ratio
2.6 Global Owren's Disorder Mergers & Acquisitions, Expansion Plans
2.7 Global Owren's Disorder Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Owren's Disorder Revenue by Company, 2018-2023
3.2 China Owren's Disorder Sales Volume by Company, 2018-2023
3.3 China Owren's Disorder Owren's Disorder Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Owren's Disorder Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Owren's Disorder Domestic VS Export
3.6 China Market, Owren's Disorder Import & Export
3.6.1 China Market, Owren's Disorder Import & Export, 2018-2029
3.6.2 China Owren's Disorder Import & Export Trends
3.6.3 Main Sources of China Owren's Disorder Import
3.6.4 Export Destination of China Owren's Disorder
4 Owren's Disorder Production by Region
4.1 Global Owren's Disorder Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Owren's Disorder Manufacturers
4.3 Global Major Manufacturers, Owren's Disorder Capacity Expansion and Future Plans
4.4 Global Owren's Disorder Capacity by Region
4.5 Global Owren's Disorder Production by Region
4.5.1 Global Owren's Disorder Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Owren's Disorder Production by Region, 2018-2023
4.5.3 Global Owren's Disorder Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Owren's Disorder Industry Chain
5.2 Owren's Disorder Upstream Analysis
5.2.1 Owren's Disorder Core Raw Materials
5.2.2 Main Manufacturers of Owren's Disorder Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Owren's Disorder Production Mode
5.6 Owren's Disorder Procurement Model
5.7 Owren's Disorder Industry Sales Model and Sales Channels
5.7.1 Owren's Disorder Sales Model
5.7.2 Owren's Disorder Typical Distributors
6 Sights by Type
6.1 Owren's Disorder Classification
6.1.1 Prothrombin Complex
6.1.2 Desamino-D-Arginine Vasopressin
6.1.3 Adrenocorticotropic Hormone
6.1.4 Antifibrinolytics
6.1.5 Other
6.2 By Type, Global Owren's Disorder Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Owren's Disorder Revenue, 2018-2029
6.4 By Type, Global Owren's Disorder Sales Volume, 2018-2029
6.5 By Type, Global Owren's Disorder Price, 2018-2029
7 Sights by Application
7.1 Owren's Disorder Segment by Application
7.1.1 Hospitals
7.1.2 Specialty Clinics
7.1.3 Other
7.2 By Application, Global Owren's Disorder Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Owren's Disorder Revenue, 2018-2029
7.4 By Application, Global Owren's Disorder Sales Volume, 2018-2029
7.5 By Application, Global Owren's Disorder Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Owren's Disorder Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Owren's Disorder Revenue, 2018-2029
8.3 By Region, Global Owren's Disorder Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Owren's Disorder Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Owren's Disorder Market Size Market Share
8.5 Europe
8.5.1 Europe Owren's Disorder Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Owren's Disorder Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Owren's Disorder Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Owren's Disorder Market Size Market Share
8.7 South America
8.7.1 South America Owren's Disorder Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Owren's Disorder Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Owren's Disorder Market Size & CAGR，2018 VS 2022 VS 2029
9.2 By Country, Global Owren's Disorder Revenue, 2018-2029
9.3 By Country, Global Owren's Disorder Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Owren's Disorder Market Size, 2018-2029
9.4.2 By Company, U.S. Owren's Disorder Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Owren's Disorder Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Owren's Disorder Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Owren's Disorder Market Size, 2018-2029
9.5.2 By Company, Europe Owren's Disorder Sales Volume Market Share, 2022
9.5.3 By Type, Europe Owren's Disorder Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Owren's Disorder Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Owren's Disorder Market Size, 2018-2029
9.6.2 By Company, China Owren's Disorder Sales Volume Market Share, 2022
9.6.3 By Type, China Owren's Disorder Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Owren's Disorder Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Owren's Disorder Market Size, 2018-2029
9.7.2 By Company, Japan Owren's Disorder Sales Volume Market Share, 2022
9.7.3 By Type, Japan Owren's Disorder Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Owren's Disorder Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Owren's Disorder Market Size, 2018-2029
9.8.2 By Company, South Korea Owren's Disorder Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Owren's Disorder Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Owren's Disorder Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Owren's Disorder Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Owren's Disorder Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Owren's Disorder Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Owren's Disorder Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Owren's Disorder Market Size, 2018-2029
9.10.2 By Company, India Owren's Disorder Sales Volume Market Share, 2022
9.10.3 By Type, India Owren's Disorder Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Owren's Disorder Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Owren's Disorder Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Owren's Disorder Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Owren's Disorder Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Owren's Disorder Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Pfizer Inc
10.1.1 Pfizer Inc Company Information, Head Office, Market Area and Industry Position
10.1.2 Pfizer Inc Owren's Disorder Models, Specifications and Application
10.1.3 Pfizer Inc Owren's Disorder Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Pfizer Inc Company Profile and Main Business
10.1.5 Pfizer Inc Recent Developments
10.2 Merck KGaA
10.2.1 Merck KGaA Company Information, Head Office, Market Area and Industry Position
10.2.2 Merck KGaA Owren's Disorder Models, Specifications and Application
10.2.3 Merck KGaA Owren's Disorder Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Merck KGaA Company Profile and Main Business
10.2.5 Merck KGaA Recent Developments
10.3 Sanofi
10.3.1 Sanofi Company Information, Head Office, Market Area and Industry Position
10.3.2 Sanofi Owren's Disorder Models, Specifications and Application
10.3.3 Sanofi Owren's Disorder Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Sanofi Company Profile and Main Business
10.3.5 Sanofi Recent Developments
10.4 Biocare Medical, LLC
10.4.1 Biocare Medical, LLC Company Information, Head Office, Market Area and Industry Position
10.4.2 Biocare Medical, LLC Owren's Disorder Models, Specifications and Application
10.4.3 Biocare Medical, LLC Owren's Disorder Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Biocare Medical, LLC Company Profile and Main Business
10.4.5 Biocare Medical, LLC Recent Developments
10.5 Lilly
10.5.1 Lilly Company Information, Head Office, Market Area and Industry Position
10.5.2 Lilly Owren's Disorder Models, Specifications and Application
10.5.3 Lilly Owren's Disorder Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Lilly Company Profile and Main Business
10.5.5 Lilly Recent Developments
10.6 Teva Pharmaceutical Industries
10.6.1 Teva Pharmaceutical Industries Company Information, Head Office, Market Area and Industry Position
10.6.2 Teva Pharmaceutical Industries Owren's Disorder Models, Specifications and Application
10.6.3 Teva Pharmaceutical Industries Owren's Disorder Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Teva Pharmaceutical Industries Company Profile and Main Business
10.6.5 Teva Pharmaceutical Industries Recent Developments
10.7 Mitsubishi Chemical Group Corporation
10.7.1 Mitsubishi Chemical Group Corporation Company Information, Head Office, Market Area and Industry Position
10.7.2 Mitsubishi Chemical Group Corporation Owren's Disorder Models, Specifications and Application
10.7.3 Mitsubishi Chemical Group Corporation Owren's Disorder Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Mitsubishi Chemical Group Corporation Company Profile and Main Business
10.7.5 Mitsubishi Chemical Group Corporation Recent Developments
10.8 Bristol-Myers Squibb Company
10.8.1 Bristol-Myers Squibb Company Company Information, Head Office, Market Area and Industry Position
10.8.2 Bristol-Myers Squibb Company Owren's Disorder Models, Specifications and Application
10.8.3 Bristol-Myers Squibb Company Owren's Disorder Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Bristol-Myers Squibb Company Company Profile and Main Business
10.8.5 Bristol-Myers Squibb Company Recent Developments
10.9 GSK plc
10.9.1 GSK plc Company Information, Head Office, Market Area and Industry Position
10.9.2 GSK plc Owren's Disorder Models, Specifications and Application
10.9.3 GSK plc Owren's Disorder Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 GSK plc Company Profile and Main Business
10.9.5 GSK plc Recent Developments
10.10 Bayer AG
10.10.1 Bayer AG Company Information, Head Office, Market Area and Industry Position
10.10.2 Bayer AG Owren's Disorder Models, Specifications and Application
10.10.3 Bayer AG Owren's Disorder Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Bayer AG Company Profile and Main Business
10.10.5 Bayer AG Recent Developments
10.11 AstraZeneca
10.11.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position
10.11.2 AstraZeneca Owren's Disorder Models, Specifications and Application
10.11.3 AstraZeneca Owren's Disorder Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 AstraZeneca Company Profile and Main Business
10.11.5 AstraZeneca Recent Developments
10.12 Zimmer Biomet
10.12.1 Zimmer Biomet Company Information, Head Office, Market Area and Industry Position
10.12.2 Zimmer Biomet Owren's Disorder Models, Specifications and Application
10.12.3 Zimmer Biomet Owren's Disorder Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Zimmer Biomet Company Profile and Main Business
10.12.5 Zimmer Biomet Recent Developments
10.13 DAIICHI SANKYO COMPANY, LIMITED
10.13.1 DAIICHI SANKYO COMPANY, LIMITED Company Information, Head Office, Market Area and Industry Position
10.13.2 DAIICHI SANKYO COMPANY, LIMITED Owren's Disorder Models, Specifications and Application
10.13.3 DAIICHI SANKYO COMPANY, LIMITED Owren's Disorder Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.13.4 DAIICHI SANKYO COMPANY, LIMITED Company Profile and Main Business
10.13.5 DAIICHI SANKYO COMPANY, LIMITED Recent Developments
10.14 Crystal Genomics Inc
10.14.1 Crystal Genomics Inc Company Information, Head Office, Market Area and Industry Position
10.14.2 Crystal Genomics Inc Owren's Disorder Models, Specifications and Application
10.14.3 Crystal Genomics Inc Owren's Disorder Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Crystal Genomics Inc Company Profile and Main Business
10.14.5 Crystal Genomics Inc Recent Developments
10.15 ABIOGEN PHARMA S.p.A
10.15.1 ABIOGEN PHARMA S.p.A Company Information, Head Office, Market Area and Industry Position
10.15.2 ABIOGEN PHARMA S.p.A Owren's Disorder Models, Specifications and Application
10.15.3 ABIOGEN PHARMA S.p.A Owren's Disorder Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.15.4 ABIOGEN PHARMA S.p.A Company Profile and Main Business
10.15.5 ABIOGEN PHARMA S.p.A Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Owren's Disorder Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Owren's Disorder Market Restraints
Table 3. Owren's Disorder Market Trends
Table 4. Owren's Disorder Industry Policy
Table 5. Global Owren's Disorder Revenue by Company, 2018-2023, US$ million
Table 6. Global Owren's Disorder Revenue Market Share by Company, 2018-2023
Table 7. Global Owren's Disorder Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Owren's Disorder Sales Volume Market Share by Company, 2018-2023
Table 9. Global Owren's Disorder Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Owren's Disorder Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Owren's Disorder Mergers & Acquisitions, Expansion Plans
Table 12. Global Owren's Disorder Manufacturers Product Type
Table 13. China Owren's Disorder Revenue by Company, 2018-2023, US$ million
Table 14. China Owren's Disorder Revenue Market Share by Company, 2018-2023
Table 15. China Owren's Disorder Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Owren's Disorder Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Owren's Disorder Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Owren's Disorder Import & Export Trends
Table 19. Main Sources of China Owren's Disorder Import
Table 20. Export Destination of China Owren's Disorder
Table 21. Global Headquarters and Manufacturing Base of Owren's Disorder Manufacturers
Table 22. Global Major Manufacturers, Owren's Disorder Capacity Expansion and Future Plans
Table 23. Global Owren's Disorder Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Owren's Disorder Production by Region, 2018-2023, (K Units)
Table 25. Global Owren's Disorder Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Owren's Disorder Upstream (Raw Materials)
Table 27. Global Owren's Disorder Typical Customers
Table 28. Owren's Disorder Typical Distributors
Table 29. By Type, Global Owren's Disorder Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Owren's Disorder Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Owren's Disorder Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Owren's Disorder Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Owren's Disorder Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Owren's Disorder Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Owren's Disorder Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Owren's Disorder Revenue Market Share, 2018-2029
Table 37. By Country, Global Owren's Disorder Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Owren's Disorder Sales Volume Market Share, 2018-2029
Table 39. Pfizer Inc Company Information, Head Office, Market Area and Industry Position
Table 40. Pfizer Inc Owren's Disorder Models, Specifications and Application
Table 41. Pfizer Inc Owren's Disorder Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Pfizer Inc Company Profile and Main Business
Table 43. Pfizer Inc Recent Developments
Table 44. Merck KGaA Company Information, Head Office, Market Area and Industry Position
Table 45. Merck KGaA Owren's Disorder Models, Specifications and Application
Table 46. Merck KGaA Owren's Disorder Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Merck KGaA Company Profile and Main Business
Table 48. Merck KGaA Recent Developments
Table 49. Sanofi Company Information, Head Office, Market Area and Industry Position
Table 50. Sanofi Owren's Disorder Models, Specifications and Application
Table 51. Sanofi Owren's Disorder Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Sanofi Company Profile and Main Business
Table 53. Sanofi Recent Developments
Table 54. Biocare Medical, LLC Company Information, Head Office, Market Area and Industry Position
Table 55. Biocare Medical, LLC Owren's Disorder Models, Specifications and Application
Table 56. Biocare Medical, LLC Owren's Disorder Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Biocare Medical, LLC Company Profile and Main Business
Table 58. Biocare Medical, LLC Recent Developments
Table 59. Lilly Company Information, Head Office, Market Area and Industry Position
Table 60. Lilly Owren's Disorder Models, Specifications and Application
Table 61. Lilly Owren's Disorder Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Lilly Company Profile and Main Business
Table 63. Lilly Recent Developments
Table 64. Teva Pharmaceutical Industries Company Information, Head Office, Market Area and Industry Position
Table 65. Teva Pharmaceutical Industries Owren's Disorder Models, Specifications and Application
Table 66. Teva Pharmaceutical Industries Owren's Disorder Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Teva Pharmaceutical Industries Company Profile and Main Business
Table 68. Teva Pharmaceutical Industries Recent Developments
Table 69. Mitsubishi Chemical Group Corporation Company Information, Head Office, Market Area and Industry Position
Table 70. Mitsubishi Chemical Group Corporation Owren's Disorder Models, Specifications and Application
Table 71. Mitsubishi Chemical Group Corporation Owren's Disorder Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Mitsubishi Chemical Group Corporation Company Profile and Main Business
Table 73. Mitsubishi Chemical Group Corporation Recent Developments
Table 74. Bristol-Myers Squibb Company Company Information, Head Office, Market Area and Industry Position
Table 75. Bristol-Myers Squibb Company Owren's Disorder Models, Specifications and Application
Table 76. Bristol-Myers Squibb Company Owren's Disorder Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Bristol-Myers Squibb Company Company Profile and Main Business
Table 78. Bristol-Myers Squibb Company Recent Developments
Table 79. GSK plc Company Information, Head Office, Market Area and Industry Position
Table 80. GSK plc Owren's Disorder Models, Specifications and Application
Table 81. GSK plc Owren's Disorder Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. GSK plc Company Profile and Main Business
Table 83. GSK plc Recent Developments
Table 84. Bayer AG Company Information, Head Office, Market Area and Industry Position
Table 85. Bayer AG Owren's Disorder Models, Specifications and Application
Table 86. Bayer AG Owren's Disorder Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Bayer AG Company Profile and Main Business
Table 88. Bayer AG Recent Developments
Table 89. AstraZeneca Company Information, Head Office, Market Area and Industry Position
Table 90. AstraZeneca Owren's Disorder Models, Specifications and Application
Table 91. AstraZeneca Owren's Disorder Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. AstraZeneca Company Profile and Main Business
Table 93. AstraZeneca Recent Developments
Table 94. Zimmer Biomet Company Information, Head Office, Market Area and Industry Position
Table 95. Zimmer Biomet Owren's Disorder Models, Specifications and Application
Table 96. Zimmer Biomet Owren's Disorder Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Zimmer Biomet Company Profile and Main Business
Table 98. Zimmer Biomet Recent Developments
Table 99. DAIICHI SANKYO COMPANY, LIMITED Company Information, Head Office, Market Area and Industry Position
Table 100. DAIICHI SANKYO COMPANY, LIMITED Owren's Disorder Models, Specifications and Application
Table 101. DAIICHI SANKYO COMPANY, LIMITED Owren's Disorder Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. DAIICHI SANKYO COMPANY, LIMITED Company Profile and Main Business
Table 103. DAIICHI SANKYO COMPANY, LIMITED Recent Developments
Table 104. Crystal Genomics Inc Company Information, Head Office, Market Area and Industry Position
Table 105. Crystal Genomics Inc Owren's Disorder Models, Specifications and Application
Table 106. Crystal Genomics Inc Owren's Disorder Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Crystal Genomics Inc Company Profile and Main Business
Table 108. Crystal Genomics Inc Recent Developments
Table 109. ABIOGEN PHARMA S.p.A Company Information, Head Office, Market Area and Industry Position
Table 110. ABIOGEN PHARMA S.p.A Owren's Disorder Models, Specifications and Application
Table 111. ABIOGEN PHARMA S.p.A Owren's Disorder Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. ABIOGEN PHARMA S.p.A Company Profile and Main Business
Table 113. ABIOGEN PHARMA S.p.A Recent Developments
List of Figure
Figure 1. Owren's Disorder Picture
Figure 2. By Revenue, Global Owren's Disorder Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Owren's Disorder Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Owren's Disorder Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Owren's Disorder Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Owren's Disorder Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Owren's Disorder Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Owren's Disorder Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Owren's Disorder Share of Global Market, 2018-2029
Figure 10. Global Owren's Disorder Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Owren's Disorder Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Owren's Disorder Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Owren's Disorder Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Owren's Disorder Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Owren's Disorder Domestic VS Export, 2022
Figure 16. Global Owren's Disorder Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Owren's Disorder Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Owren's Disorder Production Market Share & Forecast by Region, 2018-2029
Figure 19. Owren's Disorder Industry Chain
Figure 20. Owren's Disorder Procurement Model
Figure 21. Owren's Disorder Sales Model
Figure 22. Owren's Disorder Sales Channels, Direct Sales and Distribution
Figure 23. Prothrombin Complex
Figure 24. Desamino-D-Arginine Vasopressin
Figure 25. Adrenocorticotropic Hormone
Figure 26. Antifibrinolytics
Figure 27. Other
Figure 28. By Type, Global Owren's Disorder Revenue, 2018-2029, US$ Million
Figure 29. By Type, Global Owren's Disorder Revenue Market Share, 2018-2029
Figure 30. By Type, Global Owren's Disorder Sales Volume, 2018-2029, (K Units)
Figure 31. By Type, Global Owren's Disorder Sales Volume Market Share, 2018-2029
Figure 32. By Type, Global Owren's Disorder Price, 2018-2029, (US$/Unit)
Figure 33. Hospitals
Figure 34. Specialty Clinics
Figure 35. Other
Figure 36. By Application, Global Owren's Disorder Revenue, 2018-2029, US$ Million
Figure 37. By Application, Global Owren's Disorder Revenue Market Share, 2018-2029
Figure 38. By Application, Global Owren's Disorder Sales Volume, 2018-2029, (K Units)
Figure 39. By Application, Global Owren's Disorder Sales Volume Market Share, 2018-2029
Figure 40. By Application, Global Owren's Disorder Price, 2018-2029, (US$/Unit)
Figure 41. By Region, Global Owren's Disorder Revenue Market Share, 2018-2029
Figure 42. By Region, Global Owren's Disorder Sales Volume Market Share, 2018-2029
Figure 43. North America Owren's Disorder Revenue & Forecasts, 2018-2029, US$ Million
Figure 44. By Country, North America Owren's Disorder Revenue Market Share, 2022
Figure 45. Europe Owren's Disorder Revenue & Forecasts, 2018-2029, US$ Million
Figure 46. By Country, Europe Owren's Disorder Revenue Market Share, 2022
Figure 47. Asia Pacific Owren's Disorder Revenue & Forecasts, 2018-2029, US$ Million
Figure 48. By Country/Region, Asia Pacific Owren's Disorder Revenue Market Share, 2022
Figure 49. South America Owren's Disorder Revenue & Forecasts, 2018-2029, US$ Million
Figure 50. By Country, South America Owren's Disorder Revenue Market Share, 2022
Figure 51. Middle East & Africa Owren's Disorder Revenue & Forecasts, 2018-2029, US$ Million
Figure 52. U.S. Owren's Disorder Sales Volume, 2018-2029, (K Units)
Figure 53. By Company, U.S. Owren's Disorder Market Share, 2022
Figure 54. By Type, U.S. Owren's Disorder Sales Volume Market Share, 2022 VS 2029
Figure 55. By Application, U.S. Owren's Disorder Sales Volume Market Share, 2022 VS 2029
Figure 56. Europe Owren's Disorder Sales Volume, 2018-2029, (K Units)
Figure 57. By Company, Europe Owren's Disorder Market Share, 2022
Figure 58. By Type, Europe Owren's Disorder Sales Volume Market Share, 2022 VS 2029
Figure 59. By Application, Europe Owren's Disorder Sales Volume Market Share, 2022 VS 2029
Figure 60. China Owren's Disorder Sales Volume, 2018-2029, (K Units)
Figure 61. By Company, China Owren's Disorder Market Share, 2022
Figure 62. By Type, China Owren's Disorder Sales Volume Market Share, 2022 VS 2029
Figure 63. By Application, China Owren's Disorder Sales Volume Market Share, 2022 VS 2029
Figure 64. Japan Owren's Disorder Sales Volume, 2018-2029, (K Units)
Figure 65. By Company, Japan Owren's Disorder Market Share, 2022
Figure 66. By Type, Japan Owren's Disorder Sales Volume Market Share, 2022 VS 2029
Figure 67. By Application, Japan Owren's Disorder Sales Volume Market Share, 2022 VS 2029
Figure 68. South Korea Owren's Disorder Sales Volume, 2018-2029, (K Units)
Figure 69. By Company, South Korea Owren's Disorder Market Share, 2022
Figure 70. By Type, South Korea Owren's Disorder Sales Volume Market Share, 2022 VS 2029
Figure 71. By Application, South Korea Owren's Disorder Sales Volume Market Share, 2022 VS 2029
Figure 72. Southeast Asia Owren's Disorder Sales Volume, 2018-2029, (K Units)
Figure 73. By Company, Southeast Asia Owren's Disorder Market Share, 2022
Figure 74. By Type, Southeast Asia Owren's Disorder Sales Volume Market Share, 2022 VS 2029
Figure 75. By Application, Southeast Asia Owren's Disorder Sales Volume Market Share, 2022 VS 2029
Figure 76. India Owren's Disorder Sales Volume, 2018-2029, (K Units)
Figure 77. By Company, India Owren's Disorder Market Share, 2022
Figure 78. By Type, India Owren's Disorder Sales Volume Market Share, 2022 VS 2029
Figure 79. By Application, India Owren's Disorder Sales Volume Market Share, 2022 VS 2029
Figure 80. Middle East & Asia Owren's Disorder Sales Volume, 2018-2029, (K Units)
Figure 81. By Company, Middle East & Asia Owren's Disorder Market Share, 2022
Figure 82. By Type, Middle East & Asia Owren's Disorder Sales Volume Market Share, 2022 VS 2029
Figure 83. By Application, Middle East & Asia Owren's Disorder Sales Volume Market Share, 2022 VS 2029
Figure 84. Research Methodology
Figure 85. Breakdown of Primary Interviews
Figure 86. Bottom-up Approaches
Figure 87. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|